Metal-free MRI contrast agent could be safer for some patients
New agent could be used for certain high-risk groups and may enable longer-term tumor imaging.
New agent could be used for certain high-risk groups and may enable longer-term tumor imaging.
Study: Investing more in inpatient care relative to longer-term nursing facilities reduces mortality rates.
Can an antipoverty program work in different settings? A new report presents a user’s guide to a tough issue.
MIT professor wants public health advocates to think big about future trends.
Fifteen international teams developing new biomedical technologies to benefit from innovation training and expert resources.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Study at MIT Medical finds most parents are capable of performing the test.
Former Google CEO, now chairman of parent company Alphabet, speaks to students as part of fireside chat with CSAIL Director Daniela Rus.
Senior Tiffany Yeh explores health care and poverty through working abroad, and cultivates her love of music while at home.
Seed funding from the MIT Sandbox Innovation Fund helped Multiply Labs' founders launch their personalized dietary supplement startup.
By measuring this emerging vital sign, CSAIL system could help monitor and diagnose health issues like cognitive decline and cardiac disease.
Industry leaders, patient advocates, and policymakers collaborate to lower barriers to potentially curative treatments.
Microfluidic device isolates plasma cells from blood rather than bone marrow.